Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
February, 2026
February 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
232425262728  
Anticoagulants and Immunosuppressives in Behçet’s Syndrome
Arisa Chuklin/LinkedIn
Oct 22, 2025, 04:29

Anticoagulants and Immunosuppressives in Behçet’s Syndrome

Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:

”Anticoagulants and immunosuppressive therapy for thrombosis in Behçet’s syndrome: a systematic review and meta-analysis
By Arisa Chuklin, Thita Joy Chiasakul, and Noppacharn Uaprasert

• Context: Behçet’s syndrome is a systemic vasculitis often complicated by venous or arterial thrombosis, yet the optimal role of anticoagulation remains uncertain.
• Study: Across 20 studies (315 patients with disaggregated data), this meta-analysis compared relapse rates under immunosuppressives, anticoagulants, or both.
• Findings: Combination therapy markedly reduced thrombosis relapse (17.7%) versus immunosuppressives alone (43.7%) or anticoagulants alone (54.9%), supporting a dual-modality approach for vascular Behçet’s.”

Title: Anticoagulants and immunosuppressive therapy for thrombosis in Behçet’s syndrome: a systematic review and meta-analysis

Authors: Arisa Chuklin, Thita Chiasakul, Noppacharn Uaprasert

Anticoagulants

Read the article here.

Stay updated on all scientific advances with Hemostasis Today.

anticoagulants Arisa Chuklin Behçet’s Syndrome Hematology Hemostasis Today Immunosuppressive Therapy Journal of Thrombosis and Haemostasis JTH Medicine Meta-analysis Noppacharn Uaprasert Systematic Review Thita Joy Chiasakul thrombosis
NewsFeed